echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Chemicals Industry > International Chemical > DuPont U.S. medical additive base put into operation

    DuPont U.S. medical additive base put into operation

    • Last Update: 2022-10-24
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

      On June 1, DuPont announced that its new DuPont Liveo medical-grade silicone adhesive production base in Cooper River, South Carolina, USA officially opened, aiming to provide better services to customers around the world
    .
    It is reported that DuPont's other medical and health businesses will actively expand the regional production capacity layout at the Cooper River plant, so as to provide local support to customers, ease supply pressure, and support customers to achieve growth in their respective markets

    .

      Eugenio Toccalino, global business director of DuPont Healthcare and Specialty Lubricants, said that the Cooper River production base will gradually bring more extrusion capacity online in the next two years to serve strategic customers in the short term, and expand production through new production in the medium term.
    Liveo's customer base in the healthcare industry

    .
    "The investment in the Cooper River biopharmaceutical process manufacturing site is an important milestone in our growth strategy, which will support the expansion of our customers and help maintain business continuity

    .
    We are committed to investing in the healthcare sector, with recent expansions It also contributes to a more stable and sustainable supply of our products,

    " Toccalino said
    .

      In 2021, DuPont expanded the Cooper River plant with the addition of MOLYKOTE specialty lubricants capacity
    .
    Through recent investments, DuPont will continue to increase its service to the healthcare market and its customers, providing high-quality, high-performance solutions, application and materials technology expertise, and strong regulatory support to serve healthcare market customers.
    specific needs and challenges

    .

      Additionally, in the second half of 2022, DuPont expects to increase production capacity for biopharmaceutical silicone materials in China, specifically to serve fast-growing customers in the region
    .



    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.